Neurocognitive therapies for monogenic conditions: Time for a new approach?

This commentary is on the original article by Ottenhoff et al. on pages 537–549 of this issue.

Authors

Institutions

Publication Details

Journal
Developmental Medicine & Child Neurology
Published
2024-10-11
DOI
https://doi.org/10.1111/dmcn.16129
Citations
1
Primary Topic
Neurofibromatosis and Schwannoma Cases
Type
article
Field-Weighted Citation Impact
0.37
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neurocognitive therapies for monogenic conditions: Time for a new approach?

Jonathan M. Payne
1 citations
Developmental Medicine & Child Neurology
Neurofibromatosis and Schwannoma Cases
0.37
article

Neurocognitive therapies for monogenic conditions: Time for a new approach?

Jonathan M. Payne
article en
1 citations

Abstract

This commentary is on the original article by Ottenhoff et al. on pages 537–549 of this issue.

Developmental Medicine & Child NeurologyVol. 67(4)
Murdoch Children's Research Institute (AU)
Reduced inequalities
Openalex Percentile: Top 35%
Neurofibromatosis and Schwannoma Cases
0.37
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Neurocognitive therapies for monogenic conditions: Time for a new approach? — Jonathan M. Payne · Developmental Medicine & Child Neurology (2024) | TGRS Research Map | TGRS